Dystroglycan in the diagnosis of FSGS

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 11, 2009, Pages 1747-1753

  Giannico, Giovanna ^a   Yang, Haichun ^a   Neilson, Eric G ^a   Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; CALVASCULIN; WT1 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; PODOCYTE; PROTEINURIA; REMISSION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; DYSTROGLYCANS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PODOCYTES; PREDICTIVE VALUE OF TESTS; PROTEINURIA; STAINING AND LABELING; WT1 PROTEINS; YOUNG ADULT;

EID: 73449135467     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01510209     Document Type: Article

References (28)

1. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368-382, 2004
2. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184, 2008
3. Kojima K, Kerjaschki D: Is podocyte shape controlled by the dystroglycan complex?. Nephrol Dial Transplant 17[Suppl 9]: 23-24, 2002
4. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S: Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77: 675-686, 1994
5. Sugiyama J, Bowen DC, Hall ZW: Dystroglycan binds nerve and muscle agrin. Neuron 13: 103-115, 1994
6. Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LV, Fujita S, Fukuta-Ohi H, Shimizu T, Ruegg MA, Matsumura K: Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem 271: 23418-23423, 1996
7. Gesemann M, Brancaccio A, Schumacher B, Ruegg MA: Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem 273: 600-605, 1998
8. Hohenester E, Tisi D, Talts JF, Timpl R: The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin. Mol Cell 4: 783-792, 1999
9. Timpl R, Tisi D, Talts JF, Andac Z, Sasaki T, Hohenester E: Structure and function of laminin LG modules. Matrix Biol 19: 309-317, 2000
10. Raats CJ, van den Born J, Bakker MA, Oppers-Walgreen B, Pisa BJ, Dijkman HB, Assmann KJ, et al: Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 156: 1749-1765, 2000
11. Ilsley JL, Sudol M, Winder SJ: The WW domain: Linking cell signalling to the membrane cytoskeleton. Cell Signal 14: 183-189, 2002
12. Regele HM, Fillipovic E, Langer B, Poczewki H, Kraxberger I, Bittner RE, Kerjaschki D: Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 11: 403-412, 2000
13. Kojima K, Davidovits A, Poczewski H, Langer B, Uchida S, Nagy-Bojarski K, Hovorka A, Sedivy R, Kerjaschki D: Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction. J Am Soc Nephrol 15: 2079-2089, 2004
14. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74: 679-691, 1993
15. Niaudet P, Gubler MC: WT1 and glomerular diseases. Pediatr Nephrol 21: 1653-1660, 2006
16. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
17. Neilson EG: Mechanisms of disease: Fibroblasts - a new look at an old problem. Nat Clin Pract Nephrol 2: 101-108, 2006
18. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, Ichikawa I: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38: 115-123, 1990
19. Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N: Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations. Kidney Int 72: 1429-1447, 2007
20. International Study of Kidney Disease in Children: Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13: 159-165, 1978
21. Schwartz GJ, Feld LG, Langford DJ: A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104: 849-854, 1984
22. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926, 2006
23. Stokes MB, Valeri AM, Markowitz GS, D'Agati VD: Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int 70: 1783-1792, 2006
24. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58: 173-181, 2000
25. Ijpelaar DH, Farris AB, Goemaere N, Amann K, Goldschmeding R, Nguyen TQ, Farkash E, van den Heuvel MC, de Heer E, Bruijn JA, Colvin RB, Bajema IM: Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 19: 2219-2224, 2008
26. Schmid H, Henger A, Cohen CD, Frach K, Gröne HJ, Schlö ndorff D, Kretzler M: Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 14: 2958-2966, 2003
27. Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD: Glomerular tip lesion: A distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65: 1690-1702, 2004
28. Nishitani Y, Iwano M, Yamaguchi Y, Harada Y, Nakatani K, Akai Y, Nishino T, Shiiki H, Kanauchi M, Saito Y, and Eric G Neilson: Fibroblast-specific protein 1 is a prognostic marker for renal survival in patients with IgA nephropathy. Kidney Int 68: 1078-1085, 2005